Guided Solutions’ Post

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MeniscalImplants #KneeSurgery #MedicalDevices #HealthcareInnovation #OrthopedicSurgery #PatientCare #SurgicalAdvancements #GlobalMarket #MedicalResearch #HealthcareTrends

Spinal Implants Market Global Forecast to 2028 {Latest Data} 🔵𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞:https://lnkd.in/dYABKH4c The global spinal implants market in terms of revenue was estimated to be worth $11.2 Billion in 2023 and is poised to reach $14.3 Billion by 2028, growing at a CAGR of 5.0% from 2023 to 2028. 🔵 𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Johnson & Johnson MedTech NuVasive Stryker Globus Medical Zimmer Biomet Orthofix International NV ULRICH GMBH & CO. KG BKK B. Braun Melsungen AG Integra LifeSciences Holdings SAS Boston Scientific Abbott SPINEART Centinel Spine Premia Spine Exactech Life Spine Alphatec Spine Kuros Biosciences Bioventus Colfax Corporation Aesculap (US) Implanet NUUCO MEDTECH LLC D/B/A CAMBER SPINE TECHNOLOGIES Captiva Spine Medacta International Aurora Spine & Pain 🔵Key Stakeholders -Spine surgery device manufacturing companies -Distributors and suppliers of spinal surgery devices -Healthcare institutions (hospitals and outpatient clinics) -Research institutions -Research and consulting firms -Contract research organizations (CROs) and contract manufacturing organizations (CMOs) -Academic medical centers and universities -Market research and consulting firms -Hospitals -Outpatient facilities

Market Scope projects that the global retinal surgical device market—vitrectomy machines, dedicated machine packs, accessory and allied surgical products, and other devices—will total $1.3 billion in 2024 and grow to $1.6 billion by 2029, for a CAGR of 4.2 percent. Vitrectomy machine sales revenue is projected to grow at an average of around 3.5 percent per year, mainly due to practice growth and replacements of retiring machines. Several of the market leaders have recently introduced vitrectomy machine platform upgrades, including Bausch + Lomb, DORC Dutch Ophthalmic Research Center (International), and Oertli Instrumente AG. Since Alcon, the world’s leader in vitrectomy machines, has not launched a new platform since 2008—the world market share-leading Constellation—it is expected that a new Alcon machine would have a significant impact on sales. Market Scope foresees many Constellation users upgrading to the new technology. The acquisition of DORC by ZEISS Medical Technology will likely also have an impact as it extends the availability of the DORC Eva platform to new geographic markets. Dedicated packs for the installed base of vitrectomy machines are a large component of the retinal surgical device market. Once a manufacturer has sold a machine, its marketing emphasis with the user is to help increase the utilization of the machine, which increases pack sales. The average selling price of disposable surgical packs has risen, along with their popularity, and Market Scope expects these trends to continue over the next five years, increasing the revenue for dedicated packs to nearly $675 million in 2029. The market for vitrectomy accessories and allied surgical devices—such as cryosurgical consoles and instruments, light source consoles and probes, scleral buckles, silicone oil, ocular gases, and ocular dyes —is projected to total over $540 million in 2024 and is expected to grow to over $680 million in 2029, driven by the increasing installed base of vitrectomy machines and the growing number of vitrectomy surgeries. Market Scope’s newly published “2024 Retinal Surgical Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2024 market and forecasts market growth and evolution through 2029. Additionally, 21 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook. For more information or to request a sample, please visit https://bit.ly/24RetDev or email [email protected].   #Retina #Surgery #Vitrectomy #Machines #VitrectomyPacks #AlliedDevices #Ophthalmology #Ophthalmic #MarketData

𝗦𝘁𝗲𝗿𝗻𝗮𝗹 𝗖𝗹𝗼𝘀𝘂𝗿𝗲 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 Our report offers a comprehensive examination of the Sternal Closure Systems Market, amalgamating both quantitative and qualitative data. It delves into key areas such as the competitive landscape, identifying prominent manufacturers of sternal closure devices and bone cement. Additionally, it provides insights into regional dynamics, aiding in data-driven decisions by uncovering growth prospects across different regions. The report also explores the diverse range of sternal closure systems available, categorized by materials and closure techniques, thus providing a nuanced understanding of the market. Moreover, it analyzes the utilization of sternal closure systems in various surgical procedures, particularly focusing on median sternotomy for open-heart surgery. By empowering stakeholders with comprehensive company profiles, including product examples and market share estimates for 2024, the report offers valuable insights. Furthermore, with market forecasts providing segment-wise growth calculations and projections for consumption value from 2024 to 2032, businesses are equipped to target specific and lucrative market niches for maximized returns, ultimately leading to improved patient outcomes. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗦𝘁𝗲𝗿𝗻𝗮𝗹 𝗖𝗹𝗼𝘀𝘂𝗿𝗲 𝗦𝘆𝘀𝘁𝗲𝗺𝘀. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/d-4Y5aCw 💡 𝗕𝘆 𝗧𝘆𝗽𝗲: Our report explores different types of sternal closure systems, categorized by materials used (stainless steel, PEEK, titanium) and closure techniques employed (wires, plates & screws, cable systems, clips). ☀️ 𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: We analyze the utilization of sternal closure systems in various surgical procedures, primarily focused on median sternotomy for open-heart surgery, with some potential applications in minimally invasive cardiac surgery. *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa 🏢 𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: DePuy Synthes (Johnson & Johnson), Zimmer Biomet, KLS Martin Group, B. Braun Group, Stryker, Medtronic plc (for sternal stabilization products), Arthrex (for sternal stabilization products)

🛠 ZygoFix Ltd. Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System This achievement was supported by compelling clinical evidence from the company’s ongoing European clinical study, marking a significant advancement in spinal fusion technology. Spinal fusion, a common surgical procedure performed for degenerative spinal conditions such as Spondylolisthesis, Spinal Stenosis, and degenerative disc disease, traditionally requires placement of 4 screws and 2 rods, creating an artificial bridge, to stabilize the segment. The conventional invasive approach requires precise placement and building of bridges intraoperatively. ZygoFix Ltd.’s revolutionary zLOCK system harnesses the spine’s innate bone structure to securely lock its connecting joints. Unlike traditional methods, the company’s innovative implant adapts to the joint’s anatomy during insertion, offering unparalleled stability with a minimally invasive, simple procedure that can be performed in outpatient and ASC environments. With CE certification and six years of clinical utilization yielding long-term pain reduction and bone growth, ZygoFix Ltd.’s zLOCK Lumbar Facet Fixation System is positioned to revolutionize spinal fusion surgery. ZygoFix Ltd. CEO Ofer Levy remarked, “Receiving FDA clearance for our zLOCK Lumbar Stabilization System is an exciting milestone, and I am very proud of the team that has worked hard to achieve this goal. The system has garnered significant interest in the US market and this clearance paves the way for us to introduce our transformative solution to the US market, fostering collaboration with leading surgeons and enhancing patient care.” Read more online: https://lnkd.in/eTuRcbQG 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Top Medical Device Trends & Outlook for 2024 The overall forecast for the medical device market is overwhelmingly positive, with an expected global revenue of $595 billion in 2024 and a CAGR of 6.1% from 2022 to 2030. The healthcare sectors expected to be most affected by growth in the medical device space in the near future include: Cardiovascular Orthopedic Neurovascular Urological Diabetes A) In-vitro diagnostics are expected to remain the top segment in 2024, and neurology is expected to be the fastest-growing device specialty. B) Outside IVD, the expected top 10 device areas by sales in 2024 are: cardiology, diagnostic imaging, orthopedics, ophthalmics, general and plastic surgery, endoscopy, drug delivery, dental, and diabetes care. C) Diagnostic imaging and orthopedics are expected to be the slowest-growing segments next year. Within the AlphaSense platform, eight key trends have emerged to define the current and future medical device landscape . Below, cover these medical device trends and outlook for 2024 and beyond.

Direct pars fracture repair. CASE: Middle-aged active male with deliberating mechanical back pain was found to have spondylosis. After months of nonoperative treatment, a direct pars fracture repair was performed using FacetFuse. Postoperatively, his pain has significantly improved and he has returned to normal activities. https://lnkd.in/eGxSbSvF Disclaimers:  1. All facet screws are not replicas of FacetFuse. Results with copies will not reflect those of FacetFuse. 2. Our surgeons use NanoFUSE Biologics a proven proprietary 45S5 Bioglass synthetic biologics which aids fusion. We innovate, no copies! LESS Exposure Advanced Spine Technologies (LEAST) are unique technologies invented for the LESS Exposure Spine Surgery (LESS) movement. NANISX: Pioneering Interventional Spine Innovations. LESSpine: Revolutionizing Orthopedic and Neurosurgical Spine Care. We are KIC Ventures—a rapidly expanding healthtech investment firm at the forefront of the less exposure spine surgery (LESS) movement, redefining outpatient spine surgery. Join us in shaping the future of spine surgery globally. Invest smartly—become an owner in the technologies shaping tomorrow. www.KICVentures.com www.NANISX.com This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.